A recent meeting of select CDMO players in Hyderabad organized by the CII deliberated on further scope of growth for the industry, the regulatory challenges and how Indian pharma services companies can look at new opportunities out of the emerging geopolitical environment. Industry representatives specifically noted the US government’s recent moves revolving around the Biosecure Act as an interesting development for Indian drug makers.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/JnvogOY
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment